Dysregulation of DNA methyltransferases is linked to a variety of human diseases, with DNMT3A mutations particularly implicated in hematological cancers and DNMT3B mutations associated with ICF syndrome34. This evidence concerns the gene DNMT3B and hematopoietic and lymphoid cell neoplasm.